Won allocation of 82% of a $44 million Warfarin Sodium settlement for class of third party payers

Case Abstract
Representing Third Party Payers on the plaintiffs� executive committee, Richard Cohen negotiated and defended in the Third Circuit a $44.5 million class action settlement arising from illegal marketing of the prescription blood thinner Coumadin.

Client
Class of third party payers.

Case Name
In re: Warfarin Sodium Antitrust Litig., 391 F.3d 516 (3d Cir. 2004).

Result
Won allocation of 82% of a $44 million Warfarin Sodium settlement.

Case Details
After Lowey Dannenberg was appointed by the District Court to the plaintiffs� executive committee, as the representative of third party payers, the United States District Court for the District of Delaware approved a $44.5 million class action settlement paid by DuPont Pharmaceuticals to consumers and third party payers nationwide to settle claims of unfair marketing practices in connection with the prescription blood thinner Coumadin. Lowey Dannenberg then successfully defended the allocation of 82% of a $44.5 million settlement to third party payers in an appeal to the Third Circuit.